<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(1)</volume><submitter>Li J</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>To establish a juvenile mouse asthma model by postnatal hyperoxia exposure combined with early ovalbumin (OVA) sensitization.&lt;h4>Methods&lt;/h4>Female C57BL/6J newborn mice were exposed to hyperoxia (95 % O&lt;sub>2&lt;/sub>) from postnatal day-1 (PND1) to PND7; intraperitoneally injected with OVA suspension on PND21, PND28; and stimulated by nebulized inhalation of 1 % OVA from PND36 to PND42. Within 48 h of the last challenge, we observed their activity performance and evaluated airway responsiveness (AHR). All mice were executed at PND44. Female (n = 32) were divided into four groups as follows: room air（RA）+phosphate-buffered saline (PBS) group; O&lt;sub>2&lt;/sub> (hyperoxia, 95 % O&lt;sub>2&lt;/sub>) + PBS group; RA + OVA group; O&lt;sub>2&lt;/sub>+OVA group. We obtained the serum, bronchoalv</pubmed_abstract><journal>Heliyon</journal><pagination>e23291</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10750071</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Establishment of a juvenile mouse asthma model induced by postnatal hyperoxia exposure combined with early OVA sensitization.</pubmed_title><pmcid>PMC10750071</pmcid><pubmed_authors>Cao L</pubmed_authors><pubmed_authors>Tian Z</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Yu B</pubmed_authors><pubmed_authors>Ma M</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Wu R</pubmed_authors><pubmed_authors>Zhu H</pubmed_authors><pubmed_authors>Bao T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Establishment of a juvenile mouse asthma model induced by postnatal hyperoxia exposure combined with early OVA sensitization.</name><description>&lt;h4>Objective&lt;/h4>To establish a juvenile mouse asthma model by postnatal hyperoxia exposure combined with early ovalbumin (OVA) sensitization.&lt;h4>Methods&lt;/h4>Female C57BL/6J newborn mice were exposed to hyperoxia (95 % O&lt;sub>2&lt;/sub>) from postnatal day-1 (PND1) to PND7; intraperitoneally injected with OVA suspension on PND21, PND28; and stimulated by nebulized inhalation of 1 % OVA from PND36 to PND42. Within 48 h of the last challenge, we observed their activity performance and evaluated airway responsiveness (AHR). All mice were executed at PND44. Female (n = 32) were divided into four groups as follows: room air（RA）+phosphate-buffered saline (PBS) group; O&lt;sub>2&lt;/sub> (hyperoxia, 95 % O&lt;sub>2&lt;/sub>) + PBS group; RA + OVA group; O&lt;sub>2&lt;/sub>+OVA group. We obtained the serum, bronchoalv</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2025-04-05T15:53:47.132Z</modification><creation>2025-04-05T15:53:47.132Z</creation></dates><accession>S-EPMC10750071</accession><cross_references><pubmed>38148813</pubmed><doi>10.1016/j.heliyon.2023.e23291</doi></cross_references></HashMap>